Assessment of cardiac involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study

Journal of the Saudi Heart Association

Volumn 23, Issue 4, 2011, Pages 217-223

  Saleh, Ahmed ^a   Matsumori, Akira ^b   Negm, Hany ^a   Fouad, Hany ^c   Onsy, Ahmed ^c   Shalaby, Mohammed ^a   Hamdy, Enas ^d  

^a ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY OF THE ARAB REPUBLIC OF EGYPT   (Egypt)

^b UNIVERSITY OF TOKYO   (Japan)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Cardiomyopathy; Diastolic dysfunction; Hepatitis C virus; NTproBNP; Strain rate imaging; Tissue Doppler imaging

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BODY MASS; CARDIAC IMAGING; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE DOPPLER IMAGING;

EID: 80053561346     PISSN: 10167315     EISSN: 22125043     Source Type: Journal    
DOI: 10.1016/j.jsha.2011.04.005     Document Type: Article

References (14)

1. Antonelli A., et al. High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. J. Viral Hepat. 2010, 17(12):851-853.
2. Asbjørn Støylen, 2005. Strain rate imaging. Cardiac deformation imaging by ultrasound/echocardiography-tissue Doppler and Speckle tracking. Retrieved online from http://folk.ntnu.no/stoylen/strainrate/.
3. Deffic-Burban S., et al. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J. Hepatol. 2006, 44(3):455-461.
4. Demirdal T., et al. Cardiomyopathy in Patients with Chronic Hepatitis C Virus. 17th European Congress of Clinical Microbiology and Infectious Diseases 2007, ICC Munich, Germany.
5. Dimitroulas T., et al. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J. Rheumatol. 2010, 37(5):993-999.
6. Hammerer-Lercher A., et al. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers. Clin. Chem. 2004, 50:1174-1183.
7. Haykal, M., Negm, H., 2009. Cardiovasular effects of HCV in Egyptian population. CVD Prevention and Control J 4 (suppl.1).
8. Henriksen JH., Møller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand. Cardiovasc. J. 2009, 14:1-8.
9. Hunt S.A., et al. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to Update the 2001 guidelines for the evaluation and management of heart failure). J. Am. Coll. Cardiol. 2005, 46:1-82.
10. Matsumori A., et al. Myocarditis and heart failure associated with hepatitis C virus infection. J. Cardiovasc. Fail. 2006, 12(4):293-298.
11. Park H.J., et al. Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients. Int. J. Cardiol. 2010, 140(3):336-343.
12. Raedle-Hurst, et al. Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 2008, 20(9):865-873.
13. Thomas, H., Marwick et al., 2007. Myocardial Imaging: Textbook on Tissue Doppler and Speckle Tracking. Blackwell. ISBN: 978-1-4051-6113-8.
14. Yamamoto K., et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J. Cardiovasc. Fail. 2000, 6:194-200.